Simple and Complex Tics in Tourette Syndrome

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

Simple and complex tics are two ways clinicians describe repeated movements or sounds in Tourette syndrome and other tic disorders. Simple tics are brief movements or sounds that involve a small body area or a short sound, such as blinking, sniffing or throat clearing. Complex tics involve a longer pattern, several body parts, words, phrases or a coordinated sequence. The Centers for Disease Control and Prevention (CDC) describes simple tics as involving only a few parts of the body, while complex tics usually involve several body parts and can follow a pattern.

Fast comparison answer

Simple tics are usually short and limited. They may happen so quickly that other people miss them. Common examples include eye blinking, squinting, sniffing, throat clearing, shoulder shrugging and arm jerking.

Complex tics are longer or more coordinated. They may look purposeful because they can involve several movements or a phrase. Examples can include touching objects, hopping, bending, repeating words, repeating a sound pattern or moving the head while jerking an arm.

Tourette syndrome involves both motor tics and vocal tics at some point. The motor and vocal tics do not need to happen at the same time. CDC states that Tourette syndrome is diagnosed when a person has both motor and vocal tics and tic symptoms have lasted at least one year.

These labels help describe the symptom pattern. They do not decide how much support you need. A simple neck tic can be painful. A complex phrase tic can be mild. The right level of care depends on pain, safety, school, work, social stress and daily function.

Simple motor tics

Simple motor tics are brief repeated movements. They often involve the face, head, neck, shoulders, arms or hands.

Simple motor tic examples can include the following.

  • Eye blinking
  • Eye rolling
  • Squinting
  • Nose twitching
  • Facial grimacing
  • Mouth movements
  • Head jerking
  • Neck stretching
  • Shoulder shrugging
  • Arm jerking
  • Finger movements

These tics may be the first symptoms a parent notices in a child. CDC states that Tourette symptoms often begin between ages 5 and 10, and early symptoms are often motor tics in the head and neck area.

A simple motor tic can look like a habit, allergy symptom, eye problem or nervous movement. Repeated blinking may lead a family to think the child needs an eye exam. Nose twitching may be mistaken for allergies. Shoulder movements may be mistaken for restlessness.

The inner feeling can help your clinician. Some people feel pressure, tension, tightness or an urge before the movement. The movement may give short relief. Younger children may struggle to explain this feeling and may only say they “have to” move.

Simple vocal tics

Simple vocal tics are short repeated sounds. They are also called simple phonic tics in some clinical writing. Vocal tics can come from the throat, nose, mouth or breathing muscles.

Simple vocal tic examples can include the following.

  • Sniffing
  • Throat clearing
  • Coughing
  • Grunting
  • Humming
  • Clicking
  • Squeaking
  • Barking sounds
  • Short syllables

CDC lists humming, clearing the throat and yelling a word or phrase as examples of vocal tics. NINDS lists repetitive throat clearing, sniffing, barking and grunting as simple vocal tics.

Simple vocal tics can be confused with allergies, asthma, reflux, colds or intentional sounds. A throat clearing tic may be treated as a throat problem. A sniffing tic may be read as congestion. A humming tic may be seen as a classroom behavior issue.

Medical review is useful when vocal sounds are new, persistent, painful or linked with breathing symptoms, fever, swallowing problems or wheezing. A clinician can review health causes and tic patterns.

Complex motor tics

Complex motor tics involve a coordinated movement pattern. They may involve several body parts, a repeated sequence or an action that looks purposeful.

Complex motor tic examples can include the following.

  • Touching objects
  • Tapping in a repeated pattern
  • Hopping
  • Bending
  • Twisting
  • Repeating a gesture
  • Stepping in a pattern
  • Head movement combined with arm movement
  • Touching clothing or body parts repeatedly
  • Making a longer body movement sequence

CDC gives an example of a complex tic as bobbing the head while jerking an arm and then jumping up. NINDS describes complex tics as coordinated patterns of movement that can include several muscle groups.

Complex motor tics can be misunderstood because they may resemble intentional actions. A student who touches a desk repeatedly may be corrected for distracting others. An adult who repeats a gesture may worry about public judgment. The movement may still be linked to a tic urge.

Complex motor tics can also overlap with compulsive behaviors. A tic is often linked to a body urge or physical sensation. A compulsion is often linked to fear, doubt or anxiety relief. Some people have both tic symptoms and obsessive compulsive symptoms, so a clinician may need to assess the full pattern.

Complex vocal tics

Complex vocal tics involve words, phrases or repeated speech patterns. They may be brief, or they may include longer verbal sequences.

Complex vocal tic examples can include the following.

  • Repeating a word
  • Repeating a phrase
  • Saying words out of context
  • Repeating your own words
  • Repeating another person’s words
  • Yelling a phrase
  • Making a patterned sound sequence

NINDS states that complex vocal tics may include repeating one’s own words or phrases, repeating others’ words or phrases and using vulgar or socially inappropriate words.

Coprolalia means involuntary swearing or socially inappropriate language. It is widely linked with Tourette syndrome in public media, but it is rare and is not required for diagnosis. CDC states that media often portray Tourette syndrome through coprolalia or echolalia, while these symptoms are rare.

Complex vocal tics can cause stress in school, work and public settings. A word or phrase tic may be judged as intentional speech. A person may need a brief explanation, school support, workplace planning or behavioral care if the tic causes distress or disruption.

Tic patterns that change

Tics can change across days, weeks and months. A simple blinking tic may fade, then a shoulder movement may appear. A throat clearing tic may become less frequent, then a humming tic may begin. A complex tic may appear during a stressful period, then become less common.

This shifting pattern is common in Tourette syndrome and other tic disorders. The tic type, frequency, intensity and setting can all change. A person may tic more during fatigue, illness, excitement, stress, quiet settings or after suppressing symptoms for a long time.

A change in tic pattern does not automatically mean danger. Still, some changes should be reviewed promptly. Seek medical review when movements or sounds begin suddenly in adulthood, appear with confusion or loss of awareness, cause injury, affect breathing or eating, come after medication changes or occur with weakness, fever, severe headache or seizure like events.

For children, tic changes should be discussed with a clinician when symptoms last, affect school, cause pain, include both motor and vocal tics or create distress. For adults, review tic changes when they affect work, driving, pain, sleep or public settings.

Examples to track

Tracking can help a clinician see the pattern. Keep it brief. Constant checking can increase pressure around symptoms.

Useful notes can include the following.

  • First age or date when tics began
  • Simple motor tics you notice
  • Complex motor tics you notice
  • Simple vocal tics you hear
  • Complex vocal tics you hear
  • How often tics appear
  • Pain, injury or fatigue
  • School, work or social effects
  • Sleep, stress or illness patterns
  • ADHD, OCD or anxiety symptoms
  • Medication or substance changes

Short videos may help if the person with tics agrees. Tics may not appear during a short care visit. For teens and adults, ask before recording and respect privacy.

When you write notes, focus on function. A clinician needs to know if a tic affects reading, writing, speaking, sleep, driving, work tasks, public settings or pain. This helps guide care.

When simple or complex tics may need support

Support is based on impact. Mild simple or complex tics may need education and monitoring only. Tics that cause pain, injury, school problems, work limits, social stress or major distress may need treatment.

CDC states that many people with Tourette syndrome have tics that do not interfere with daily life and do not need treatment, while behavioral treatment and medication may help when tics cause pain, injury or interfere with school, work or social life.

CBIT, known as Comprehensive Behavioral Intervention for Tics, may help some children, teens and adults. It teaches awareness of tic urges, competing responses and changes to settings that make tics harder to manage. Medication may be discussed when tics are severe, painful or disruptive. Medication decisions require a qualified healthcare professional.

Support may also include school accommodations, workplace changes, pain care, therapy for anxiety, OCD care, ADHD treatment or family education.

Links to motor tics and vocal tics

If your main concern is movement, a motor tics guide can help you review eye blinking, facial movements, shoulder shrugging, head jerking, touching and other movement symptoms.

If your main concern is sound, a vocal tics guide can help you review throat clearing, sniffing, coughing, humming, words, phrases and public misunderstandings.

If you need the wider symptom picture, a Tourette syndrome symptoms guide can connect simple and complex tics with premonitory urges, age patterns, tic changes and care visit preparation.

If you are comparing diagnoses, a tic disorder guide can help explain Tourette syndrome, persistent motor or vocal tic disorder and provisional tic disorder.

Research context

Tic research studies brain circuits, development, genetics, behavioral treatment, medication safety, related conditions and daily support needs. Better research can help clinicians match care to symptom patterns and life impact.

Regulated psychedelic research may help scientists study brain networks, neuroplasticity and future therapeutic models. Psilocybin is not an established treatment for simple tics, complex tics, Tourette syndrome or tic disorders. Any future research in this area should use clear diagnostic criteria, validated tic measures, careful safety review and attention to ADHD, OCD and anxiety.

As you review simple and complex tics, symptom patterns and future research questions, we at Rose Hill Life Sciences approach this topic through science led education. Our work focuses on psychedelic research, production and study of Psilocybe cubensis, the intersection of science and therapeutic integration and our Massachusetts research work, while tic diagnosis and treatment decisions should remain with qualified healthcare professionals.

Conclusion

If you notice simple or complex tics, write down the tic type, when it began, how long it has lasted and how it affects daily life. Include motor tics, vocal tics, pain, school issues, work limits, social stress and safety concerns.

If tics are mild and do not disrupt life, ask a clinician about monitoring. If tics cause pain, injury, distress or daily limits, ask about a fuller evaluation and support options.

If both motor and vocal tics are present, mention both during the visit. That detail can affect diagnosis and care planning.

Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.